Colorado Receives FDA Approval For Its Canadian Prescription Drug Importation Program

The U.S. Food and Drug Administration (FDA) has authorized Colorado's Section 804 Importation Program (SIP), allowing the state to import certain prescription medications from Canada. The authorization is valid for two years and is intended to help reduce prescription drug costs through lower insurance premiums and out-of-pocket expenses.

The FDA determined that Colorado's proposal satisfies the requirements of Section 804 of the Federal Food, Drug, and Cosmetic Act and 21 CFR Part 251. According to the approval letter, importation under the program is expected to significantly reduce costs to consumers without creating additional risks to . . .